GILD

Gilead Sciences, Inc. News Headlines

$69.28
*  
1.11
 negative 
1.63%
Get GILD Alerts
*Delayed - data as of Apr. 16, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Affymetrix Rise on Turnaround 2Q Earnings - Analyst Blog
8/7/2013 12:25:01 PM - Zacks.com

Rigel Pharma Narrows Q2 Loss - Analyst Blog
8/7/2013 11:41:00 AM - Zacks.com

Endo Health Beats on Earnings & Revs. in Q2 - Analyst Blog
8/7/2013 11:40:01 AM - Zacks.com

Earnings Beat at Regeneron in Q2 - Analyst Blog
8/6/2013 12:40:51 PM - Zacks.com

Zoetis Reports In-Line Earnings in Q2 - Analyst Blog
8/6/2013 12:13:01 PM - Zacks.com

A Biotech And Pharmaceutical RX
8/5/2013 8:26:00 PM - Seeking Alpha

Affymetrix Sees Earnings After Two Years - Analyst Blog
8/5/2013 1:40:07 PM - Zacks.com

Anika Soars on Strong Q2 Results - Analyst Blog
8/5/2013 9:07:39 AM - Zacks.com

China Biotech In Review: China's Rx Market To Total $315 Billion In 2020
8/4/2013 2:35:00 AM - Seeking Alpha

6 Oncology-Focused Biotech Growth Engines: Mara Goldstein
8/2/2013 6:01:00 PM - Seeking Alpha

Earnings Beat at AstraZeneca in 2Q - Analyst Blog
8/2/2013 10:08:01 AM - Zacks.com

PCYC Reports Earnings in Q2, Revs Surge - Analyst Blog
8/1/2013 1:17:01 PM - Zacks.com

Earnings Increase at Bayer in 2Q - Analyst Blog
8/1/2013 10:23:03 AM - Zacks.com

Cubist Pharma Announces Acquisition Deals - Analyst Blog
7/31/2013 2:21:50 PM - Zacks.com

Earnings Beat at Hospira in 2Q, Sales In Line - Analyst Blog
7/31/2013 12:01:01 PM - Zacks.com

Amgen Beats on Earnings & Revs in Q2 - Analyst Blog
7/31/2013 11:21:52 AM - Zacks.com

Gilead Sciences Hepatitis C Approval May Be Factored In
7/30/2013 6:02:00 PM - Seeking Alpha

Gilead Nuc Forecasts At Unprecedented Levels - Where To Set Stock Expectations
7/30/2013 2:31:00 PM - Seeking Alpha

Zacks #1 Rank Additions for Tuesday - Tale of the Tape
7/30/2013 9:30:01 AM - Zacks.com

After Hours Most Active for Jul 29, 2013 : ELN, PFE, HLF, QQQ, HAL, ZTS, CAT, MU, FB, GILD, AGNC, PDLI
7/29/2013 4:44:53 PM - NASDAQ.com News

Best Stocks: Isis, Gilead, Celgene, and Regeneron Take Over the Top Ranks
7/29/2013 9:20:00 AM - Minyanville

Can the Recent Uptrend Continue for Gilead Sciences, Inc. (GILD)? - Tale of the Tape
7/29/2013 6:29:09 AM - Zacks.com

Onconova's Public Debut: What You'll Want To Know
7/26/2013 5:24:00 PM - Seeking Alpha

Wall Street Happy To Hum La AbbVie En Rose
7/26/2013 1:17:00 PM - Investopedia

Cramer's Mad Money - Facebook's Triumph (7/25/13)
7/26/2013 5:59:00 AM - Seeking Alpha